Home
GoodRx Holdings GDRX paid S-3 Group $80K for lobbying in Q2 2026 · Pharmacy, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q2 2026
- Stock
- GoodRx Holdings GDRX
- Client
- Goodrx
- Reported
- 26/07/17
Up 33.3% from last quarter
What else happened in GoodRx Holdings around then
Filed or reported within 30 days of the trade day · 05/31~07/30Goodrx's other lobbying reports
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$60K
$60K
Reported 07/20
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$380K
$380K
Reported 07/20
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$90K
$90K
Reported 07/19
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$60K
$60K
Reported 04/21
for Q1
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$370K
$370K
Reported 04/20
for Q1